We found that the combined treatment of ghrelin and GH inhibited TGF-β production, attenuated lymphopenia, corrected monocytosis and basophilia in the blood, downregulated the expression of cleaved caspase-3 and PD-1, and upregulated the expression of HLA-DR in the spleen. The gene discussed is GH1; the disease is lymphopenia.